Search clinical trials for: Varenicline Tartarate

Total 819 results

Korea University Anam Hospital

Completed

A Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HIP1502

Healthy

Korea, Republic of
Pfizer

Completed

A Single Dose Study Investigating the Absorption and Elimination as Well as the Tolerability of Varenicline Transdermal Delivery System (e.g., a Patch) as Compared to Oral Varenicline in Adult Smokers.

Smoking Cessation

United States
Pfizer

Completed

Smoking Cessation in Subjects With Mild-to-moderate Chronic Obstructive Pulmonary Disease (COPD).

Smoking Cessation

United States, France, Italy, Spain
Pfizer

Completed

Multiple Dose, Dose Escalation Study of Varenicline Controlled Release Formulation in Adult Smokers

Smoking Cessation

United States
Ji Xing Pharmaceuticals (Shanghai) Co., Ltd.
Oyster Point Pharma, Inc.

Completed

Clinical Trial to Evaluate the Efficacy and Safety of OC-01 (Varenicline) Nasal Spray on Signs and Symptoms of Dry Eye Disease

Dry Eye Disease

China
Oyster Point Pharma, Inc.

Completed

Evaluating Relative Bioavailability of OC-01 (Varenicline) Nasal Spray as Compared to Orally Administered Varenicline

Healthy Subjects

United States
Ji Xing Pharmaceuticals (Shanghai) Co., Ltd.
Oyster Point Pharma, Inc.

Completed

Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of OC-01 in Adult Chinese With Dry Eye Disease

Dry Eye Disease

China
Yale University

Completed

Varenicline for Treatment of E-cigarette Dependence

Smoking Cessation

United States
Pfizer

Completed

Phase 1 Clinical Trial of Varenicline in Chinese Healthy Smoking Volunteers

Smoking

China
Pfizer

Completed

An Investigation of Effectiveness and Safety of Varenicline Tartrate in Helping People Quit Smoking

Smoking Cessation

Thailand, Singapore, China
Pfizer

Completed

A Study To Evaluate The Efficacy And Safety Of Varenicline Compared To Placebo For Smoking Cessation Through Reduction

Smoking Cessation

United States, Taiwan, Australia, Germany, Egypt, United Kingdom, Canada, Czech Republic, Mexico, Japan
Pfizer

Completed

An Investigation Of The Effects Of Food On The Absorption Of A Varenicline Controlled Release Formulation

Smoking Cessation | Pharmacokinetics | Bioavailability

United States
University of Kansas Medical Center

Recruiting

Switching to E-cigarettes in African-American Smokers

Smoking Reduction

United States
The Queen Elizabeth Hospital

Completed

Smoking Termination Opportunity for inPatients (STOP)

Tobacco Use Disorder

Australia
University of Sao Paulo General Hospital
Fundação de Amparo à Pesquisa do Estado de São Paulo

Completed

Efficacy of the Use of Genetic Markers in the Choice of the Pharmacological Treatment of Smoking (GENTSMOKING) (GENTSMOKING)

Smoking Cessation | Genetic Predisposition

Brazil
Pfizer

Completed

Study Evaluating The Efficacy Of Varenicline In Cessation Of Oral Smokeless Tobacco Use

Tobacco Use Cessation

Norway, Sweden
Pfizer

Completed

Assessment of Safety and Efficacy of Varenicline in Patients That Wish to Stop Smoking

Smoking Cessation

Colombia, Mexico, Egypt, Jordan, Brazil, Costa Rica, Lebanon, Saudi Arabia, South Africa, United Arab Emirates, Venezuela
Mayo Clinic

Completed

Varenicline Treatment for Active Alcoholic Smokers

Smoking | Alcohol Dependence | Tobacco Dependence

United States
NYU Langone Health
Pfizer

Withdrawn

Study of Varencline Effects on Cigarette Smoking Reward and Craving During a Model of Brief Quit Attempt (VarenSmoke)

Nicotine Dependence

United States
Mayo Clinic

Completed

Varenicline For Smokers In Recovery From Alcohol Dependence

Tobacco Abstinence

United States
American University of Beirut Medical Center
Pfizer

Completed

Varenicline (Chantix) Treatment for Waterpipe Smoking Cessation

Nicotine Dependence

Lebanon
Assistance Publique - Hôpitaux de Paris

Unknown

Randomized Trial of Electronic Cigarettes With or Without Nicotine in Smoking Cessation. (ECSMOKE)

Smoking Cessation | Smoking, Cigarette | Electronic Cigarette

France
University of Oulu
Lapland Central Hospital Rovaniemi Finland

Completed

Efficacy and Safety of E-cigarettes for Smoking Cessation in Middle-aged Heavy Smokers (EFFECT)

Smoking Cessation | Electronic Cigarette

Finland
Arizona State University
National Institute on Drug Abuse (NIDA); Pfizer; University of Nevada, Reno; Los...

Completed

Varenicline OTC Trial on Efficacy and Safety (VOTC)

Smoking Cessation | Withdrawal Symptoms | Tobacco Dependence

United States
Pfizer

Withdrawn

A Study to Evaluate the Safety and Efficacy of Three Doses of a Controlled Release Formulation of Varenicline for Smoking Cessation

Smoking Cessation
University of California, Los Angeles
National Institute on Drug Abuse (NIDA)

Completed

An Assessment of the Safety of Varenicline in Methamphetamine-dependent Volunteers

Methamphetamine Addiction | Crystal Meth Addiction | Amphetamine Addiction

United States
University of Chicago
Pfizer

Completed

Varenicline Augmentation of Patch Outcomes in Heavy Drinkers' Smoking Cessation

Alcohol Drinking | Smoking Cessation

United States
Philip Diaz
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Smoking Cessation Using Motivational Therapy and Varenicline

HIV Infections | Smoking

United States
Butler Hospital
Brown University

Completed

Study of Mood Effects of Varenicline (Chantix) in Depressed Outpatient Smokers

Depressive Disorder | Smoking

United States
Medical University of South Carolina

Completed

Hollings Cancer Center Varenicline Sampling Study

Smoking | Smoking Cessation | Smoking, Tobacco | Smoking, Cigarette

United States
University of Wisconsin, Madison
National Cancer Institute (NCI)

Enrolling by invitation

Cessation Screening Project

Nicotine Dependence

United States
Pfizer

Completed

Smoking Cessation Study In Healthy Adolescent Smokers

Smoking Cessation

United States, Korea, Republic of, Taiwan, Canada, Georgia, Russian Federation
Pfizer

Completed

A Study Evaluating The Absorption Of Varenicline Into The Body From A Varenicline Solution And A Varenicline Patch Applied To The Skin

Smoking Cessation

United States
Duke University
National Institute on Drug Abuse (NIDA); Pfizer

Completed

Adaptive Pharmacotherapy for Smoking Cessation

Nicotine Dependence

United States
Albert Einstein College of Medicine
National Institute on Drug Abuse (NIDA); Pfizer; National Institutes of Health...

Active, not recruiting

A Trial of Directly Observed and Long-term Varenicline

Tobacco Use Disorder | Opioid-use Disorder

United States
Pontis Biologics, Inc.
Salus Research, Inc., 1220 Medical Park Dr. A, Fort Wayne ID 46825; Reinhard...

Completed

Testing if Tartarase Can Remove Dental Tartar

Dental Calculus

United States
University of Minnesota

Completed

Improving Varenicline Adherence and Outcomes in Homeless Smokers

Tobacco Use Cessation

United States
Massachusetts General Hospital

Terminated

Chantix in Adult Smokers With Attention Deficit Hyperactivity Disorder (ADHD)

Smoking Cessation | Attention Deficit/Hyperactivity Disorder
Amicus Therapeutics

Completed

A Long-Term Extension Study of AT2101 (Afegostat Tartrate) in Type 1 Gaucher Patients

Gaucher Disease | Gaucher Disease, Type 1 | Type 1 Gaucher Disease

United Kingdom, United States
Pfizer

Completed

A Twelve-Week Study of Varenicline for Safety and Efficacy in Comparison With Placebo for Smoking Cessation

Smoking Cessation

Korea, Republic of, Taiwan
Oyster Point Pharma, Inc.

Completed

Clinical Trial to Evaluate the Chronic Efficacy of OC-01 Nasal Spray on Signs of Dry Eye Disease (The MYSTIC Study)

Dry Eye Disease

Mexico
Vastra Gotaland Region

Completed

Varenicline and Bupropion for Alcohol Use Disorder

Alcohol Dependence | Alcoholism | Alcohol Use Disorder

Sweden
Medical University of South Carolina

Completed

Impact of Varenicline on Blood-Oxygen-Level Dependent (BOLD) Functional Magnetic Resonance Imaging (fMRI) Activation on Smokers (GRAND)

Nicotine Dependence

United States
University of South Florida
Pfizer; National Ataxia Foundation; Bob Allison Ataxia Research Center (BAARC)

Completed

Study to Determine the Safety and Tolerability of Varenicline (Chantix®) in Treating Spinocerebellar Ataxia Type 3

Spinocerebellar Ataxia Type 3

United States
Amicus Therapeutics

Completed

A Study of AT2101 (Afegostat Tartrate) in Adult Patients With Type 1 Gaucher Disease Currently Receiving Enzyme Replacement Therapy

Gaucher Disease | Gaucher Disease, Type 1 | Type 1 Gaucher Disease

United States
Amicus Therapeutics

Completed

A Study of Oral AT2101 (Afegostat Tartrate) in Treatment-naive Patients With Gaucher Disease

Gaucher Disease | Gaucher Disease, Type 1 | Type 1 Gaucher Disease

United Kingdom, Israel, South Africa, United States
Roswell Park Cancer Institute
Pfizer

Completed

An Alternative Dosing Schedule of Varenicline for Smoking Cessation

Smoking Cessation

United States
Memorial Sloan Kettering Cancer Center
Pfizer

Terminated

Tobacco Dependence in Breast Cancer Patients Trial of Varenicline (Chantix)

Breast Cancer | Tobacco Dependence

United States
Pfizer

Completed

ASIA CHOICES CHampix (Varenicline) Observational Investigation in the CEssation of Smoking (ASIA CHOICES)

Smoking Cessation

Korea, Republic of, China, Philippines, India
Pfizer

Completed

12 Week Evaluation of the Safety and Efficacy of 3 Doses of CP-526,555 and Placebo for Smoking Cessation

Smoking Cessation

Japan

Search clinical trials for: Varenicline Tartarate

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Australia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations